The function of Golgi apparatus in LRRK2-associated Parkinson's disease

被引:4
|
作者
Wei, Yonghang [1 ]
Awan, Maher un Nisa [1 ]
Bai, Liping [1 ]
Bai, Jie [1 ]
机构
[1] Kunming Univ Sci & Technol, Med Sch, Lab Mol Neurobiol, Kunming, Peoples R China
来源
FRONTIERS IN MOLECULAR NEUROSCIENCE | 2023年 / 16卷
基金
中国国家自然科学基金;
关键词
Parkinson's; LRRK2; Rab29; VPS52; PKC; Golgi apparatus; ANIMAL-MODELS; LRRK2; KINASE; FRAGMENTATION; PROTEINS; PHOSPHORYLATION; TRAFFICKING; RAB; MUTATIONS; TRANSPORT;
D O I
10.3389/fnmol.2023.1097633
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a chronic neurodegenerative disease associated with the intracellular organelles. Leucine-rich repeat kinase 2 (LRRK2) is a large multi-structural domain protein, and mutation in LRRK2 is associated with PD. LRRK2 regulates intracellular vesicle transport and function of organelles, including Golgi and lysosome. LRRK2 phosphorylates a group of Rab GTPases, including Rab29, Rab8, and Rab10. Rab29 acts in a common pathway with LRRK2. Rab29 has been shown to recruit LRRK2 to the Golgi complex (GC) to stimulate LRRK2 activity and alter the Golgi apparatus (GA). Interaction between LRRK2 and Vacuolar protein sorting protein 52 (VPS52), a subunit of the Golgi-associated retrograde protein (GARP) complex, mediates the function of intracellular soma trans-Golgi network (TGN) transport. VPS52 also interacts with Rab29. Knockdown of VPS52 leads to the loss of LRRK2/Rab29 transported to the TGN. Rab29, LRRK2, and VPS52 work together to regulate functions of the GA, which is associated with PD. We highlight recent advances in the roles of LRRK2, Rabs, VPS52, and other molecules, such as Cyclin-dependent kinase 5 (CDK5) and protein kinase C (PKC) in the GA, and discuss their possible association with the pathological mechanisms of PD.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] LRRK2 and idiopathic Parkinson's disease
    Rocha, Emily M.
    Keeney, Matthew T.
    Di Maio, Roberto
    De Miranda, Briana R.
    Greenamyre, J. Timothy
    TRENDS IN NEUROSCIENCES, 2022, 45 (03) : 224 - 236
  • [22] LRRK2 in Parkinson's disease: in vivo models and approaches for understanding pathogenic roles
    Yue, Zhenyu
    FEBS JOURNAL, 2009, 276 (22) : 6445 - 6454
  • [23] Preclinical modeling of chronic inhibition of the Parkinson's disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo
    Kluss, Jillian H.
    Mazza, Melissa Conti
    Li, Yan
    Manzoni, Claudia
    Lewis, Patrick A.
    Cookson, Mark R.
    Mamais, Adamantios
    MOLECULAR NEURODEGENERATION, 2021, 16 (01)
  • [24] Structure of LRRK2 in Parkinson's disease and model for microtubule interaction
    Deniston, C. K.
    Salogiannis, J.
    Mathea, S.
    Snead, D. M.
    Lahiri, I.
    Matyszewski, M.
    Donosa, O.
    Watanabe, R.
    Bohning, J.
    Shiau, A. K.
    Knapp, S.
    Villa, E.
    Reck-Peterson, S. L.
    Leschziner, A. E.
    NATURE, 2020, 588 (7837) : 344 - 349
  • [25] LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting
    Xiong, Yulan
    Yu, Jianzhong
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (10) : 982 - 996
  • [26] Exploring the focal role of LRRK2 kinase in Parkinson's disease
    Kumar, Sachin
    Behl, Tapan
    Sehgal, Aayush
    Chigurupati, Sridevi
    Singh, Sukhbir
    Mani, Vasudevan
    Aldubayan, Maha
    Alhowail, Ahmed
    Kaur, Satvinder
    Bhatia, Saurabh
    Al-Harrasi, Ahmed
    Subramaniyan, Vetriselvan
    Fuloria, Shivkanya
    Fuloria, Neeraj Kumar
    Sekar, Mahendran
    Daim, Mohamed M. Abdel
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2022, 29 (22) : 32368 - 32382
  • [27] Recent Developments in LRRK2-Targeted Therapy for Parkinson's Disease
    Zhao, Ye
    Dzamko, Nicolas
    DRUGS, 2019, 79 (10) : 1037 - 1051
  • [28] α-Synuclein Gene Hypomethylation in LRRK2 Parkinson's Disease Patients
    de Mena, Lorena
    Pares, Guillem
    Garrido, Alicia
    Pilco-Janeta, Daniel F.
    Fernandez, Manel
    Perez, Jesica
    Tolosa, Eduardo
    Camara, Ana
    Valldeoriola, Francesc
    Ezquerra, Mario
    Marti, Maria-Jose
    Fernandez-Santiago, Ruben
    MOVEMENT DISORDERS, 2024, : 550 - 555
  • [29] The Multifaceted Role of LRRK2 in Parkinson's Disease
    Ho, Dong Hwan
    Han, Sun Jung
    Son, Ilhong
    BRAIN SCIENCES, 2025, 15 (04)
  • [30] Mutations in LRRK2 as a cause of Parkinson's disease
    Giasson, Benoit I.
    Van Deerlin, Vivianna M.
    NEUROSIGNALS, 2008, 16 (01) : 99 - 105